Navigation Links
Cell Therapeutics Updates Shareholders on Trading
Date:2/11/2009

SEATTLE, Feb. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) announced today that the Borsa Italiana, which is the entity that governs the trading of the Company's common stock on the MTA stock market in Milan, Italy, suddenly suspended trading of the Company's shares in Italy on February 10th. As a result of the suspension of trading by the Borsa Italiana, the security has additionally been halted on the NASDAQ Stock Market pursuant to Marketplace Rule 4120(a)(4) when a security is also registered on a foreign securities exchange and the foreign securities exchange halts trading in such security for regulatory reasons. We have not been advised of any independent basis for NASDAQ's decision to halt trading.

The Company's common stock has traded on the MTA since 2004 and is thus required to comply with the rules and regulations of the Commissione Nazionale per le Societe e la Borsa, or CONSOB, which is the public authority responsible for regulating the Italian securities markets and the Borsa Italiana, which oversees the trading market in Italy. Collectively these agencies regulate companies listed on Italy's public markets. The Company has responded to numerous requests by both the Borsa Italiana and CONSOB to provide additional clarifications about its business operations and financial condition, and the Company has met with CONSOB on several occasions, most recently on February 6th, to answer such questions. As in the past, the Company believes it has complied with CONSOB's requests to issue additional press releases in Italy and if required filed as Form 8-K in the US clarifying the information contained in the Company's SEC filings and press releases and the Company is committed to continuing to do so. The Company is waiting for clarification from the Borsa Italiana and CONSOB as to what additional information or action the Company must take, if any, for the Borsa Italiana to resum
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results
2. Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
3. Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2009 Financial Results on Wednesday, February 11th, at 4:30 P.M. EST
4. Transition Therapeutics Announces Completion of Patient Enrolment of Phase 2 Study of TT-223 in Type 2 Diabetes Patients
5. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
6. Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference
7. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
8. AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics
9. Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
10. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
11. Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... ... Santa Rosa’s The Press Democrat announced its annual report of the very best facilities in ... Furnas took the top spot as the Best Cosmetic Surgeons in Sonoma County . ... be bestowed such a prestigious title. , The Press Democrat was Santa Rosa’s ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Hospital examines outcomes for inmates who continued methadone maintenance treatment (MMT) during incarceration ... more likely to relapse to opiate use (1) and more likely to require ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Morristown Medical ... New Jersey, and one of the first five hospitals in the nation, to implant ... three patients on July 23, and all are in good condition. , The CoreValve® ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Healthline , ... a recent survey (1) examining consumers’ perspectives on digital health . The ... covered topics such as innovations in digital health, level of trust in the security ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently gave ... took place from noon to 1 p.m. Tuesday, June 23, at the Gulf Coast ... , Dr. Ahmad is board-certified in colorectal surgery and has more than 35 years ...
Breaking Medicine News(10 mins):Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2
... Governor Walker to join University of Utah ... SAN JOSE, Calif., July 16 Olene Walker has been interviewed ... this month will likely be the most compelling from the former Utah governor. ... her personal struggle with a fatal lung disease. , ...
... , ALEXANDRIA, Va., July 16 Ensuring that ... the event of a healthcare crisis is what advance care ... Care Organization,s Caring Connections, a leading provider of advance care ... the availability and accessibility of advance care planning information and ...
... , Archer: "We,re Determined to Make the House Bill ... for Reform " , , ... director Diane Archer today praised the House for introducing a health reform ... Health Choices Act is designed to control costs and deliver quality affordable health care ...
... , , COLUMBUS, Ohio, July 16 ... visits is the goal of a new program announced by the Ohio ... The Medicaid plans serve families and dependent children, a group that includes ... , Keep Up with Checkups will ...
... unable to get LASIK, researchers say , THURSDAY, July ... laser-assisted eye surgery may benefit from implantable lenses made ... noted that LASIK "has gained widespread popularity as a ... but patients with high [severe] myopia or thin corneas ...
... , WORCESTER, Mass., July 16 Board-certified facial ... and only FDA-approved microsphere-enhanced collagen filler for the correction of smile ... dermal filler. Dr. Fechner has been an avid Artefill user the ... the correction of deep wrinkles. , , ...
Cached Medicine News:Health News:Former Utah Governor to Talk About Her Battle With PF on ABC 4 Salt Lake City, July 22nd 2Health News:Former Utah Governor to Talk About Her Battle With PF on ABC 4 Salt Lake City, July 22nd 3Health News:National Hospice and Palliative Care Organization's Caring Connections and Google Health Offer New Way to Access Advance Directives Online 2Health News:'Keep Up With Checkups' Puts Prevention First 2Health News:New Option for Correcting Nearsightedness 2Health News:Facial Plastic Surgeon Dr. Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 2Health News:Facial Plastic Surgeon Dr. Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 3
(Date:7/28/2015)... 2015 Amgen (NASDAQ: AMGN ) announced ... per share dividend for the third quarter of 2015. ... to all stockholders of record as of the close ... About Amgen Amgen is committed to unlocking the potential ... discovering, developing, manufacturing and delivering innovative human therapeutics. This ...
(Date:7/28/2015)...   Regulus Therapeutics Inc . ( NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that it ... ended June 30, 2015 on Tuesday, August 4, 2015, ... Regulus will host a conference call and webcast on ... Time to discuss its second quarter 2015 financial results ...
(Date:7/28/2015)... Calif. , July 28, 2015 On ... Corp., the parent company of CPI International, Inc. (CPI), ... quarter ended July 3, 2015 with the Securities and ... its results for the quarter.  At 11 a.m. (EDT) ... telephonic conference call in conjunction with this release that ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3CPI International To Announce Third Quarter 2015 Financial Results 2
... of Body Consistent with Overall PASI ... Response in REMICADE-Treated Patients, SAN ANTONIO, Feb. ... trials showed patients with moderate,to severe plaque psoriasis receiving REMICADE(R) ... of the four body regions,(head, trunk, lower and upper extremities) ...
... PRINCETON, N.J., Feb. 4 Pharmacopeia (Nasdaq:,PCOP), an ... small,molecule therapeutics, today announced that Dr. Leslie J. ... corporate presentation at the,BIO CEO & Investor Conference ... at The Waldorf-Astoria Hotel in New York City., ...
Cached Medicine Technology:REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10Pharmacopeia to Present at BIO CEO & Investor Conference 2008 2Pharmacopeia to Present at BIO CEO & Investor Conference 2008 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: